<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37929276</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1860</ISSN><JournalIssue CitedMedium="Internet"><Volume>223</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp</ISOAbbreviation></Journal><ArticleTitle>S&#xed;ndrome de Wiskott-Aldrich en Espa&#xf1;a: incidencia, mortalidad y sesgo de g&#xe9;nero durante 21 a&#xf1;os.</ArticleTitle><Pagination><StartPage>262</StartPage><EndPage>269</EndPage><MedlinePgn>262-269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rce.2023.02.008</ELocationID><Abstract><AbstractText Label="ANTECEDENTES" NlmCategory="UNASSIGNED">El s&#xed;ndrome de Wiskott-Aldrich (SWA) es un raro trastorno ligado al cromosoma X que se considera que afecta predominantemente a varones.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">El objetivo de este estudio consist&#xed;a en investigar la incidencia y la mortalidad intrahospitalaria del SWA en Espa&#xf1;a, as&#xed; como el sesgo de g&#xe9;nero.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Se llev&#xf3; a cabo un estudio epidemiol&#xf3;gico retrospectivo poblacional en 97 pacientes con SWA diagnosticados en hospitales espa&#xf1;oles entre 1997 y 2017, utilizando para ello datos del Sistema Nacional de Vigilancia de Datos Hospitalarios.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Nuestros resultados revelaron que la incidencia anual media del SAW en Espa&#xf1;a fue de 1,1 caso por cada 10 millones de habitantes (IC del 95 %, 0,45-2,33). El riesgo relativo fue mayor en los varones que en las mujeres (2,42). El diagn&#xf3;stico de SWA se establece a una edad m&#xe1;s avanzada en las mujeres (mediana de 47 a&#xf1;os) que en los varones (mediana de 5,5 a&#xf1;os). &#xda;nicamente los varones ingresaron en el hospital en al menos 10 ocasiones diferentes y todas las muertes se detectaron en varones. La tasa de mortalidad intrahospitalaria fue del 9,28 % en el SAW y la mayor&#xed;a de las muertes se asociaron a hemorragia cerebral o infecci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">El SWA, una enfermedad rara, se diagnostica a una edad m&#xe1;s avanzada en las mujeres y la mortalidad se observ&#xf3; exclusivamente en varones, asociada en la mayor&#xed;a de los casos a hemorragia cerebral e infecci&#xf3;n.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Espejo</LastName><ForeName>Antonio Guerrero</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n de Enfermedades Infecciosas, Facultad de Medicina y Odontolog&#xed;a, Universidad Cat&#xf3;lica de Valencia "San Vicente M&#xe1;rtir", Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dols</LastName><ForeName>Sof&#xed;a Tom&#xe1;s</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n de Enfermedades Infecciosas, Facultad de Medicina y Odontolog&#xed;a, Universidad Cat&#xf3;lica de Valencia "San Vicente M&#xe1;rtir", Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gestal</LastName><ForeName>M&#xf3;nica C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Servicio de Microbiolog&#xed;a e Inmunolog&#xed;a. LSU Health, 71103, Shreveport, LA, Estados Unidos.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI127335</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM134974</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp</MedlineTA><NlmUniqueID>8608576</NlmUniqueID><ISSNLinking>0014-2565</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Espa&#xf1;a</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de Wiskott-Aldrich</Keyword><Keyword MajorTopicYN="N">epidemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">incidencia</Keyword><Keyword MajorTopicYN="N">mortalidad</Keyword><Keyword MajorTopicYN="N">mujeres</Keyword></KeywordList><CoiStatement>8.Conflictos de intereses Los autores declaran carecer de conflictos de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37929276</ArticleId><ArticleId IdType="mid">NIHMS1895939</ArticleId><ArticleId IdType="pmc">PMC10621733</ArticleId><ArticleId IdType="doi">10.1016/j.rce.2023.02.008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008;15(1):30&#x2013;6. 10.1097/MOH.0b013e3282f30448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e3282f30448</ArticleId><ArticleId IdType="pubmed">18043243</ArticleId></ArticleIdList></Reference><Reference><Citation>Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: A comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26&#x2013;43. 10.1111/nyas.12049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12049</ArticleId><ArticleId IdType="pubmed">23527602</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich Syndrome: The Actin Cytoskeleton and Immune Cell Function. Dis Markers. 2010;29(3&#x2013;4). 10.1155/2010/781523</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/781523</ArticleId><ArticleId IdType="pmc">PMC3835520</ArticleId><ArticleId IdType="pubmed">21178275</ArticleId></ArticleIdList></Reference><Reference><Citation>Garkaby J, Upton J. Wiskott-Aldrich syndrome caused by a novel mutation in the WAS gene and presenting with a mild phenotype. LymphoSign J. 2021;8(3). 10.14785/lymphosign-2021-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.14785/lymphosign-2021-0022</ArticleId></ArticleIdList></Reference><Reference><Citation>Candotti F. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. J Clin Immunol. 2018;38:13&#x2013;27. 10.1007/s10875-017-0453-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-017-0453-z</ArticleId><ArticleId IdType="pubmed">29086100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhakar M, Rikhi R, Loganathan SK, Suri D, Singh S. Autoimmunity in wiskott&#x2013;aldrich syndrome: Updated perspectives. Appl Clin Genet. 2021;14(20):363&#x2013;88. 10.2147/TACG.S213920</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S213920</ArticleId><ArticleId IdType="pmc">PMC8384432</ArticleId><ArticleId IdType="pubmed">34447261</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N. Hodgkin&#x2019;s and non-Hodgkin&#x2019;s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol. 2011;14(1). 10.2350/10-01-0787-CR.1</Citation><ArticleIdList><ArticleId IdType="doi">10.2350/10-01-0787-CR.1</ArticleId><ArticleId IdType="pubmed">20429642</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: Diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55&#x2013;66. 10.2147/TACG.S58444</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S58444</ArticleId><ArticleId IdType="pmc">PMC4012343</ArticleId><ArticleId IdType="pubmed">24817816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for wiskott&#x2013; aldrich syndrome: Improved outcome and quality of life. J Blood Med. 2021;12:435&#x2013;47. 10.2147/JBM.S232650</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JBM.S232650</ArticleId><ArticleId IdType="pmc">PMC8206065</ArticleId><ArticleId IdType="pubmed">34149291</ArticleId></ArticleIdList></Reference><Reference><Citation>Candotti F. Gene therapy for Wiskott-Aldrich syndrome: here to stay. Lancet Haematol. 2019;6(5):e230&#x2013;1. 10.1016/S2352-3026(19)30066-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30066-3</ArticleId><ArticleId IdType="pubmed">30981782</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AJ, Sokolic R, Logan B, Yin Z, Iyengar S, Scalchunes C, et al. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. J Clin Immunol. 2019;39(8):786&#x2013;94. 10.1007/s10875-019-00689-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-019-00689-2</ArticleId><ArticleId IdType="pmc">PMC7385986</ArticleId><ArticleId IdType="pubmed">31620947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrua F, Cicalese MP, Galimberti S, Giannelli S, Dionisio F, Barzaghi F, et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. Lancet Haematol. 2019;6(5):e239&#x2013;53. 10.1016/S2352-3026(19)30021-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30021-3</ArticleId><ArticleId IdType="pmc">PMC6494976</ArticleId><ArticleId IdType="pubmed">30981783</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani A, Semeraro M, Adam F, Booth C, Dupr&#xe9; L, Morris EC, et al. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott&#x2013;Aldrich syndrome. Nat Med. 2022. Jan 1 [cited 2022 May 2];28(1):71&#x2013;80. 10.1038/S41591-021-01641-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01641-X</ArticleId><ArticleId IdType="pmc">PMC8799465</ArticleId><ArticleId IdType="pubmed">35075289</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal N, Sridhar DC, Malay S, Patil N, Shekar A, Ahuja S, et al. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care. Sci Rep. 2021;11(1):1&#x2013;7. 10.1038/s41598-021-84328-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84328-0</ArticleId><ArticleId IdType="pmc">PMC7907136</ArticleId><ArticleId IdType="pubmed">33633315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacein-Bey Abina S, Gaspar HB, Blondeau J, Caccavelli L, Charrier S, Buckland K, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA - J Am Med Assoc. 2015;313(15):1550&#x2013;63. 10.1001/jama.2015.3253</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3253</ArticleId><ArticleId IdType="pmc">PMC4942841</ArticleId><ArticleId IdType="pubmed">25898053</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero A, Torres P, Duran MT, Ruiz-D&#xed;ez B, Rosales M, Rodriguez-Tudela JL. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet. 2001;357(9264):1267&#x2013;8. 10.1016/S0140-6736(00)04423-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04423-8</ArticleId><ArticleId IdType="pubmed">11418156</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero A, Cobo J, Fort&#xfa;n J, Navas E, Quereda C, Asensio A, et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet. 1997. Dec 13;350(9093):1738&#x2013;42. 10.1016/S0140-6736(97)07567-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(97)07567-3</ArticleId><ArticleId IdType="pubmed">9413465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Worth A, Thrasher AJ, Burns SO. How I manage patients with Wiskott Aldrich syndrome. Br J Haematol. 2019;185(4):647&#x2013;55. 10.1111/bjh.15831</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.15831</ArticleId><ArticleId IdType="pmc">PMC7612067</ArticleId><ArticleId IdType="pubmed">30864154</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, et al. X&#x2013;linked thrombocytopenia and Wiskott&#x2013;Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9(4):414&#x2013;7. 10.1038/ng0495-414</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0495-414</ArticleId><ArticleId IdType="pubmed">7795648</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolini O, Ressmann G, Oskar A. Haas O, Pawlowsky J, Gadner H, Knapp W, et al. X-Linked Wiskott&#x2013;Aldrich Syndrome in a Girl. N Engl J Med. 1998;338(5):291&#x2013;5. 10.1056/NEJM199801293380504</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199801293380504</ArticleId><ArticleId IdType="pubmed">9445409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM. Carrier detection in the Wiskott Aldrich syndrome. Blood. 1988;72(5):1735&#x2013;9. 10.1182/blood.v72.5.1735.1735</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v72.5.1735.1735</ArticleId><ArticleId IdType="pubmed">3263154</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. X-Chromosome inactivation in the Wiskott-Aldrich syndrome: A marker for detection of the carrier state and identfication of cell lineages expressing the gene defect. Genomics. 1989;4(1):60&#x2013;7. 10.1016/0888-7543(89)90315-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-7543(89)90315-7</ArticleId><ArticleId IdType="pubmed">2563352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wengler BG, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Cell. 1995;85(9):2471&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7537115</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonyawat B, Dhanraj S, Al Abbas F, Zlateska B, Grunenbaum E, Roifman CM, et al. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol. 2013;33(7):1150&#x2013;5. 10.1007/s10875-013-9927-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-013-9927-9</ArticleId><ArticleId IdType="pubmed">23943155</ArticleId></ArticleIdList></Reference><Reference><Citation>Conley M, Wang W, Parolini O, Shapiro DN, Campana D, Siminovitch KA. Atypical Wiskott-Aldrich Syndrome in a Girl. Blood. 1992;80(5):1264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1515642</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SJ, Nisen PD. Random X chromosome inactivation in a female with a variant of Wiskott&#x2010;Aldrich syndrome. Br J Haematol 1995;90(1):210&#x2013;2. 10.1111/j.13652141.1995.tb03403.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.13652141.1995.tb03403.x</ArticleId><ArticleId IdType="pubmed">7786787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondoh T, Hayashi K, Matsumoto T, Yoshimoto M, Morio T, Yata J, et al. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: Is the condition in the family autosomal recessive? Am J Med Genet - Neuropsychiatr Genet. 1995;60(5):364&#x2013;9. 10.1002/ajmg.1320600504</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.1320600504</ArticleId><ArticleId IdType="pubmed">8546147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children. J Clin Immunol. 1988;8(6):479&#x2013;85. 10.1007/BF00916954</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00916954</ArticleId><ArticleId IdType="pubmed">3065352</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892&#x2013;1979). J Pediatr. 1980;97(1):72&#x2013;8. 10.1016/s0022-3476(80)80133-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(80)80133-8</ArticleId><ArticleId IdType="pubmed">7381651</ArticleId></ArticleIdList></Reference><Reference><Citation>Blancas-Galicia L, Escamilla-Quiroz C, Yamazaki-Nakashimada MA. S&#xed;ndrome de Wiskott-Aldrich; revisi&#xf3;n actualizada. Rev Alerg Mex. 2011;58(4):213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24007832</ArticleId></ArticleIdList></Reference><Reference><Citation>Stucki U, Spycher MA, Eich G, Rossi A, Sacher P, Steinmann B, et al. Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome. Am J Med Genet. 2001;100(2):116&#x2013;21. 10.1002/ajmg.1228</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.1228</ArticleId><ArticleId IdType="pubmed">11298372</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu N, Garc&#xed;a-Rodr&#xed;guez M, Volpini V, Frecha C, Molina IJ, Fontan G, et al. A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals. J Hum Genet [Internet]. 2006;51(2):92&#x2013;7. Available from: 10.1007/s10038-005-03287</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10038-005-03287</ArticleId><ArticleId IdType="pubmed">16372137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment. Biol Blood Marrow Transplant. 2009;15(1, Supplement):84&#x2013;90. 10.1016/j.bbmt.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2008.10.007</ArticleId><ArticleId IdType="pubmed">19147084</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamoros Flor&#xed; N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G. Primary Immunodeficiency Syndrome in Spain: First Report of the National Registry in Children and Adults. J Clin Immunol. 1997;17(4):333&#x2013;9. 10.1023/a:1027382916924</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1027382916924</ArticleId><ArticleId IdType="pubmed">9258772</ArticleId></ArticleIdList></Reference><Reference><Citation>Stray-Pedersen A, Abrahamsen TG, Fr&#xf8;land SS. Primary Immunodeficiency Diseases in Norway. J Clin Immunol. 2000;20(6):477&#x2013;85. 10.1023/a:1026416017763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1026416017763</ArticleId><ArticleId IdType="pubmed">11202238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheminant M, Mahlaoui N, Desconclois C, Canioni D, Ysebaert L, Dupr&#xe9; L, et al. Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: Analysis of the French Registry of Primary Immunodeficiencies. J Allergy Clin Immunol. 2019;143(6):2311&#x2013;2315.e7. 10.1016/j.jaci.2019.01.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.01.046</ArticleId><ArticleId IdType="pubmed">30796981</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): Hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104(13):4010&#x2013;9. 10.1182/blood-2003-05-1592</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-05-1592</ArticleId><ArticleId IdType="pubmed">15284122</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood 2004. Jan 15;103(2):456&#x2013;64. 10.1182/blood-2003-051480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-051480</ArticleId><ArticleId IdType="pubmed">12969986</ArticleId></ArticleIdList></Reference><Reference><Citation>De Saint Basile G, Lagelouse RD, Lambert N, Schwarz K, Le Mareck B, Odent S, et al. Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J Pediatr. 1996;129(1):56&#x2013;62. 10.1016/S0022-3476(96)70190-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(96)70190-7</ArticleId><ArticleId IdType="pubmed">8757563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariga T, Yamada M, Wada T, Saitoh S, Sakiyama Y. Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome. Br J Haematol. 1999;104(4):893&#x2013;900. 10.1046/j.1365-2141.1999.01248.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.1999.01248.x</ArticleId><ArticleId IdType="pubmed">10192456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O&#x2019;Donnell E. Wiskott-Aldrich syndrome in a female. Blood. 2002. Oct 15;100(8):2763&#x2013;8. 10.1182/blood-2002-02-0388</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-02-0388</ArticleId><ArticleId IdType="pubmed">12351383</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu N, Pujol-Moix N, Martinez-Lostao L, Oset M, Mu&#xf1;iz-Diaz E, Estivill X, et al. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells, Mol Dis. 2003;31(3):332&#x2013;7. 10.1016/S1079-9796(03)00168-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1079-9796(03)00168-2</ArticleId><ArticleId IdType="pubmed">14636648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Sun J, Liu C, Hao J. Case Report: Wiskott-Aldrich Syndrome Caused by Extremely Skewed X-Chromosome Inactivation in a Chinese Girl. Front Pediatr. 2021;9(July):1&#x2013;5. 10.3389/fped.2021.691524</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.691524</ArticleId><ArticleId IdType="pmc">PMC8295588</ArticleId><ArticleId IdType="pubmed">34307257</ArticleId></ArticleIdList></Reference><Reference><Citation>Takimoto T, Takada H, Ishimura M, Kirino M, Hata K, Ohara O, et al. Wiskott-aldrich syndrome in a girl caused by heterozygous WASP mutation and extremely skewed X-chromosome inactivation: A novel association with maternal uniparental isodisomy 6. Neonatology. 2015;107(3):185&#x2013;90. 10.1159/000370059</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000370059</ArticleId><ArticleId IdType="pubmed">25633059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6 PART 1):876&#x2013;85. 10.1016/S00223476(05)82002-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S00223476(05)82002-5</ArticleId><ArticleId IdType="pubmed">7996359</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri D, Rikhi R, Jindal AK, Rawat A, Sudhakar M, Vignesh P, et al. Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India. Front Immunol. 2021;12(April):1&#x2013;14. 10.3389/fimmu.2021.627651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.627651</ArticleId><ArticleId IdType="pmc">PMC8086834</ArticleId><ArticleId IdType="pubmed">33936041</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>